Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Protara Therapeutics (TARA) Other Non Operating Income (2016 - 2025)

Protara Therapeutics' Other Non Operating Income history spans 8 years, with the latest figure at $249000.0 for Q4 2025.

  • Quarterly Other Non Operating Income changed N/A to $249000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $730000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $730000.0 for FY2025, 88.63% up from the prior year.
  • Other Non Operating Income came in at $249000.0 for Q4 2025, down from $481000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $481000.0 in Q1 2025 to a low of $249000.0 in Q4 2025.